This is a non-core endpoint: only basic statistics are computed.
See its core counterpart C3_PALATE_EXALLC for full statistics.
Malignant neoplasm of palate
C3_PALATE
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
84 |
4. Check minimum number of eventsNone |
84 |
5. Include endpointsNone |
84 |
6. Filter based on genotype QC (FinnGen only) |
84 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 5
- First used in FinnGen datafreeze
- DF9
Similar endpoints
↥List of similar endpoints to
Malignant neoplasm of palate
based on the number of shared cases.
Similar with more cases:
- Malignant neoplasm of palate, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm of oral cavity
- Malignant neoplasm of oral cavity, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm of head and neck
- Malignant neoplasm of head and neck, excluding all cancers (controls excluding all cancers)
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 84 | 36 | 48 |
| Unadjusted period prevalence (%) | 0.02 | 0.01 | 0.02 |
| Median age at first event (years) | 65.31 | 65.72 | 64.99 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 77
- Matched controls
- 771
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
C05.1
ICD-10 Finland
Malignant neoplasm: Soft palate
+∞
46.7
40
*
EHB00
NOMESCO Finland
Excision of lesion of palate
+∞
33.9
30
*
504
Kela drug reimbursment
Conditions requiring daily forced enteral nutrition
215.7
28.8
28
*
8070/3-C05.1
ICD-O-3
Squamous cell carcinoma, NOS, of soft palate, NOS
+∞
25.4
23
*
C05.0
ICD-10 Finland
Malignant neoplasm: Hard palate
+∞
24.2
22
*
JDB10
NOMESCO Finland
Percutaneous gastrostomy
77.0
23.9
26
5
EN1BD
NOMESCO Finland
Very extensive CT examination of mouth and soft tissues of neck
107.3
22.1
23
*
EHA10
NOMESCO Finland
Biopsy of palate
68.4
21.7
24
5
130
Kela drug reimbursment
Malignant tumour
12.0
16.7
33
45
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
22.6
16.6
24
15
EEB00
NOMESCO Finland
Partial excision of maxilla
183.4
15.0
15
*
EP1AE
NOMESCO Finland
Neck ultrasound examination
16.7
14.3
23
19
WF002
NOMESCO Finland
Radical radiotherapy
13.7
14.1
25
26
WZC05
NOMESCO Finland
Specialty-specific consultation based on referral by dentist or doctor
22.0
13.9
20
12
GBB00
NOMESCO Finland
Tracheostomy
35.7
13.6
17
6
R4190
NOMESCO Finland
Nutritional therapy
20.3
13.5
20
13
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
8.2
11.6
28
50
PJD81
NOMESCO Finland
Excision of lymph nodes from upper part of neck
38.5
10.7
13
*
8070/3-C05.9
ICD-O-3
Squamous cell carcinoma, NOS, of palate, NOS
+∞
10.7
10
*
SBB10
NOMESCO Finland
Teeth copy
11.6
10.3
19
21
N02AA05
ATC
oxycodone; systemic
6.0
9.9
31
78
EBA10
NOMESCO Finland
Surgical removal of tooth
9.2
9.9
21
30
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
13.3
9.9
17
16
EP1CG
NOMESCO Finland
Extensive MRI examination of soft tissue of neck with high intesity magnet
25.6
9.7
13
6
C03.0
ICD-10 Finland
Malignant neoplasm: Upper gum
113.4
9.6
10
*
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
113.4
9.6
10
*
ZZQ00
NOMESCO Finland
Free microvascular graft of skin
113.4
9.6
10
*
YA1VG
NOMESCO Finland
MRI examination of head and neck with high intesity magnet for dose design of radiotherapy
42.1
9.3
11
*
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
4.5
9.2
51
232
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
9.3
9.2
19
26
UDQ12
NOMESCO Finland
Flexible laryngoscopy
11.1
9.1
17
19
SAA03
NOMESCO Finland
Extended examination of mouth
4.4
8.9
46
193
SPF20
NOMESCO Finland
Temporary soling for filling
56.7
8.9
10
*
C05.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of palate
+∞
8.5
8
*
C05.9
ICD-10 Finland
Malignant neoplasm: Palate, unspecified
+∞
8.5
8
*
SAA04
NOMESCO Finland
Special inverstigation of mouth
13.9
8.5
14
12
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
4.3
8.5
44
183
WX110
NOMESCO Finland
Local anesthesy
5.8
8.3
67
414
K08.2
ICD-10 Finland
Atrophy of edentulous alveolar ridge
25.2
8.3
11
5
EP1DG
NOMESCO Finland
Very extensive examination of soft tissue of neck with high intesity magnet
50.3
7.9
9
*
SBB00
NOMESCO Finland
Fotograf of mouth and teeth
15.5
7.7
12
9
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
4.8
7.5
27
77
K13.79
ICD-10 Finland
Change in the oral mucosa UNS
18.0
7.5
11
7
A07AA02
ATC
nystatin; oral
8.5
7.5
16
23
8070/3-C05.0
ICD-O-3
Squamous cell carcinoma, NOS, of hard palate
+∞
7.4
7
*
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
5.3
7.2
23
57
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
8.6
7.1
15
21
SBA00
NOMESCO Finland
Microbiological examinations
18.8
6.9
10
6
UJC01
NOMESCO Finland
Scopy of lower throat
44.1
6.9
8
*
WX408
NOMESCO Finland
General anesthesy, balanced
3.8
6.9
37
149
A03FA01
ATC
metoclopramide; systemic, rectal
4.2
6.9
29
96
EJA10
NOMESCO Finland
Biopsy of tongue or floor of mouth
25.1
6.8
9
*
EBA15
NOMESCO Finland
Extraction of large number of teeth
14.0
6.8
11
9
WF003
NOMESCO Finland
Adjuvant radiotherapy
9.5
6.6
13
16
A06AD11
ATC
lactulose; oral
5.0
6.6
22
57
ZX090
NOMESCO Finland
Other technic of radiotherapy
10.7
6.6
12
13
K13.29
ICD-10 Finland
Indefinite leukoplakia
75.9
6.5
7
*
SPA00
NOMESCO Finland
Changing form of teeth in prepation for prothetic work
7.9
6.4
14
21
EN1AD
NOMESCO Finland
CT examination of mouth and soft tissues of neck
29.3
6.4
8
*
YA1CD
NOMESCO Finland
Very extensive CT examination of head and neck for dose design of radiotherapy
29.3
6.4
8
*
C04.1
ICD-10 Finland
Malignant neoplasm: Lateral floor of mouth
+∞
6.3
6
*
ENB00
NOMESCO Finland
Excision or exploration of lesion of pharynx
+∞
6.3
6
*
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
9.9
6.3
12
14
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
11.4
6.3
11
11
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
8.0
6.0
13
19
WX402
NOMESCO Finland
General anaesthesia
4.0
6.0
26
87
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(4035726)
37
66
9.23
22.24
1.7
1.3
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
60
271
5.25
11.65
3.7
2.0
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
33
95
5.07
11.32
5.2
5.2
mmol/l
1.0
1.0
0.42
33
90
(3007853) Bacteria identified in Skin by Aerobe culture
28
76
5.03
10.19
1.8
1.8
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
11
12
10.40
9.18
1.4
1.2
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
42
179
3.69
8.03
4.5
4.6
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
61
336
3.98
7.78
7.8
6.3
mmol/l
1.2
1.2
1.20
51
288
(3002256) Pathology report gross observation
25
76
4.26
7.71
1.4
1.2
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
56
294
3.71
7.64
6.1
4.0
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
53
279
3.44
6.99
9.0
6.7
inr
1.1
1.2
0.26
12
79
(3044640) Blood type and Crossmatch panel - Blood
43
208
3.19
6.39
3.9
2.4
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
21
67
3.85
5.96
1.7
2.0
%
1.7
1.7
0.03
16
58
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
35
156
3.13
5.89
3.1
2.3
—
—
—
0
0
(40758558) Short blood count panel - Blood
35
172
2.77
4.78
8.0
7.0
—
—
—
0
0
(3018418) pH of Serum or Plasma
40
211
2.71
4.75
4.1
3.8
ph
7.4
7.4
0.30
12
32
(3000494) Fungus identified in Specimen by Culture
21
81
3.12
4.38
3.7
1.5
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
25
110
2.81
4.13
1.6
1.8
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
24
104
2.83
4.07
2.0
2.1
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
20
79
3.01
3.99
1.5
1.6
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
59
400
2.60
3.91
13.5
8.9
e9/l
4.3
4.1
0.22
52
351
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
14
49
3.23
3.38
3.5
3.8
mmol/l
1.3
1.2
0.97
14
42
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
8
15
5.77
3.28
1.4
1.2
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
52
351
2.26
3.22
6.0
5.7
e9/l
0.2
0.2
0.33
44
311
(3019198) Lymphocytes [#/volume] in Blood
51
343
2.24
3.17
5.8
5.7
e9/l
1.5
1.8
1.06
44
306
(3000991) Gas panel - Venous blood
15
57
2.99
3.16
4.1
7.8
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
46
297
2.21
3.16
13.2
9.7
e9/l
0.0
0.0
0.50
35
238
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
19
84
2.63
3.05
1.6
1.6
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
50
337
2.19
3.05
5.8
5.6
e9/l
0.7
0.6
1.55
43
293
(3006315) Basophils [#/volume] in Blood
50
337
2.19
3.05
5.8
5.7
e9/l
0.0
0.0
0.61
43
292
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
7
14
5.35
2.79
1.3
1.4
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
11
40
3.01
2.48
3.5
5.3
mmol/l
24.8
24.4
0.11
11
40
(3026389) Candida sp identified in Specimen by Organism specific culture
5
8
6.56
2.40
2.2
1.0
—
—
—
0
0
(3019060) Gas panel - Arterial blood
12
48
2.75
2.30
8.2
4.5
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
40
271
1.91
2.18
2.4
2.0
pmol/l
96.9
94.9
0.09
31
136
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
10
39
2.78
2.00
1.4
1.7
—
—
—
0
0
(3020891) Body temperature
8
27
3.16
1.99
7.4
5.0
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
77
676
2.67
1.94
27.1
14.0
mg/l
31.3
24.0
1.40
71
525
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
58
454
1.90
1.93
3.4
3.0
u/l
56.1
47.9
0.35
53
425
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
9
34
2.84
1.93
1.4
1.4
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
5
12
4.36
1.85
1.6
1.8
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
5
12
4.36
1.85
1.2
1.3
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
34
229
1.81
1.82
6.2
5.1
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
11
48
2.49
1.79
1.7
1.5
—
—
—
0
0
(3000492) Spirometry study
12
55
2.38
1.77
2.1
1.4
—
—
—
0
0
(3012544) pH of Venous blood
13
62
2.30
1.76
2.1
3.5
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
23
139
1.90
1.71
2.0
1.6
nmol/l
1230.8
1204.7
0.05
18
107
(3018095) Leukocytes [#/volume] in Urine
36
253
1.74
1.64
2.8
3.8
e6/l
46.4
36.7
0.14
20
193
(3027315) Oxygen [Partial pressure] in Blood
5
14
3.73
1.64
1.4
2.6
kpa
9.2
8.8
—
5
14
(3013290) Carbon dioxide [Partial pressure] in Blood
5
14
3.73
1.64
1.4
2.6
kpa
5.2
5.0
—
5
14
(3017143) Hepatitis C virus Ab [Presence] in Serum
13
65
2.18
1.59
1.7
1.6
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
25
160
1.80
1.55
1.7
1.3
—
—
—
0
0
(3044889) 12 lead EKG panel
61
505
1.76
1.47
4.7
4.0
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
15
82
2.01
1.47
1.4
1.4
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
5
16
3.25
1.46
1.8
1.8
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
5
16
3.25
1.46
1.6
1.8
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
56
458
1.67
1.36
3.4
4.0
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
8
34
2.49
1.33
2.9
2.1
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
27
185
1.68
1.31
2.1
2.9
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
20
127
1.75
1.26
1.9
2.7
e6/l
1.9
0.9
—
9
77
(40760888) Immunoglobulin light chains.free panel - Serum
5
19
2.73
1.23
1.0
3.3
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
12
65
1.99
1.20
4.9
3.3
—
—
—
0
0
(4034850)
0
33
0.00
1.19
0.0
13.6
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
45
359
1.55
1.14
2.2
2.5
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
16
242
0.58
1.12
3.9
3.0
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
29
210
1.58
1.11
2.3
3.0
e6/l
2.0
0.3
0.61
19
162
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
9
45
2.12
1.09
1.7
2.0
ng/l
85.6
114.9
—
9
39
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
7
33
2.22
1.08
7.0
8.0
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
17
111
1.67
0.97
2.2
2.4
umol/l
10.4
14.4
1.56
17
98
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
17
112
1.65
0.94
2.1
3.0
e6/l
0.6
1.8
—
6
63
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
6
28
2.23
0.93
2.0
2.3
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
11
64
1.83
0.91
1.2
1.4
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
27
202
1.50
0.88
2.4
2.8
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
8
45
1.86
0.87
2.1
1.6
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
17
237
0.65
0.82
3.5
4.0
mg/mmol
13.2
12.0
0.05
12
147
(3002582) Erythrocytes [#/volume] in Urine
29
224
1.45
0.80
2.5
3.1
e6/l
50.1
57.4
0.08
18
181
(4010399)
10
59
1.79
0.80
1.6
1.5
—
—
—
0
0
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
5
23
2.25
0.77
1.4
1.1
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
10
61
1.73
0.72
2.4
2.5
g/l
65.6
67.1
—
10
53
(3009542) Hematocrit [Volume Fraction] of Blood
67
611
1.48
0.68
24.3
14.6
%
38.1
40.2
1.73
48
435
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
71
655
1.54
0.68
24.2
13.7
ml/min/173m2
82.8
78.5
0.93
65
524
(3012516) Albumin [Mass/volume] in Urine
17
227
0.69
0.65
3.0
3.2
mg/l
70.2
67.1
0.03
12
149
(36660697) Celiac disease serology panel - Serum
8
51
1.63
0.62
1.4
1.2
—
—
—
0
0
(3022313) Gas panel - Capillary blood
5
30
1.71
0.62
3.4
3.0
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
31
253
1.36
0.61
2.6
3.2
—
—
—
0
0
(3013512) EKG study
17
224
0.70
0.60
3.3
4.0
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
26
207
1.37
0.59
1.9
1.9
u/l
88.9
272.6
1.39
26
195
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
63
679
0.71
0.59
5.4
4.8
mmol/l
5.7
6.0
2.32
58
621
(3026782) Osmolality of Urine
18
139
1.38
0.49
2.1
2.8
mosm/kgh2o
589.2
556.3
0.20
13
117
(3007164) IgA [Mass/volume] in Serum or Plasma
16
121
1.40
0.49
1.1
1.5
g/l
2.9
2.4
—
10
69
(40761535) Cells panel - Urine sediment
8
56
1.47
0.44
4.4
3.3
—
—
—
0
0
(3020564) Creatinine [Moles/volume] in Serum or Plasma
77
735
1.57
0.42
31.2
16.7
umol/l
74.4
80.1
1.18
77
735
(3014051) Protein [Presence] in Urine by Test strip
0
15
0.00
0.41
0.0
1.7
—
—
—
0
0
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
5
34
1.50
0.41
1.6
2.3
%
0.7
0.7
—
5
34
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
0
18
0.00
0.40
0.0
1.4
—
—
—
0
0
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
5
35
1.46
0.40
1.6
2.3
%
1.8
1.2
—
5
35
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
21
251
0.78
0.38
4.1
4.5
%
17.4
21.2
—
10
113
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
6
43
1.43
0.36
1.2
1.4
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
12
92
1.36
0.34
6.5
8.3
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
7
51
1.41
0.32
2.4
3.5
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
75
722
1.36
0.30
23.3
12.9
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
12
148
0.78
0.27
5.1
4.1
—
1.0
—
0
14
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
66
688
0.81
0.26
4.2
4.8
mmol/l
1.5
1.5
0.02
59
627
(46235355) HIV 1 and 2 tests - Meaningful Use set
9
74
1.24
0.26
1.3
1.7
—
—
—
0
0
(3022145) Colonoscopy Study observation
6
84
0.69
0.25
1.3
1.2
—
—
—
0
0
(3004119) Hemoglobin [Mass/volume] in Venous blood
5
37
1.37
0.24
1.8
2.8
g/l
119.6
127.6
—
5
37
(3011397) Hemoglobin [Presence] in Urine by Test strip
18
154
1.21
0.23
3.7
3.5
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
25
279
0.85
0.22
4.0
4.1
ng/l
22.0
26.2
0.51
18
201
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
68
704
0.82
0.22
4.6
5.5
mmol/l
2.6
2.7
0.46
61
641
(3029937) Albumin [Presence] in Urine by Test strip
16
186
0.83
0.22
4.4
3.6
estimate
0.0
0.0
—
8
56
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
0
11
0.00
0.21
0.0
1.9
—
—
—
0
0
(4268621)
0
10
0.00
0.21
0.0
1.7
—
—
—
0
0
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
3.7
—
81.8
—
0
10
(40768795) Lymph node Pathology biopsy report
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence
0
10
0.00
0.21
0.0
1.5
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
0
12
0.00
0.21
0.0
2.0
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
23
253
0.87
0.16
3.9
3.8
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
35
326
1.13
0.16
3.3
3.6
estimate
0.0
0.0
—
8
62
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
17
191
0.86
0.16
2.2
2.8
ug/l
1.0
0.7
—
10
124
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
65
667
0.89
0.11
3.9
4.2
mmol/l
1.4
1.3
0.38
58
606
(3021601) Nitrite [Presence] in Urine by Test strip
35
333
1.09
0.09
4.5
4.9
estimate
0.0
0.0
—
8
63
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
6
54
1.12
0.09
1.7
2.6
ug/l
2.3
6.9
—
6
47
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
5
63
0.78
0.08
1.2
2.0
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
16
147
1.11
0.08
5.8
4.6
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
35
336
1.07
0.07
3.3
3.6
estimate
0.0
0.0
—
8
56
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
23
217
1.08
0.07
2.8
3.4
ng/l
1232.1
1203.1
0.03
23
183
(40768797) Stomach Pathology biopsy report
10
90
1.13
0.06
1.3
1.3
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
68
691
0.92
0.05
4.2
4.8
mmol/l
4.6
4.6
0.03
61
636
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
62
630
0.94
0.04
4.2
4.4
mu/l
2.1
2.0
0.27
56
561
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
52
512
1.04
0.02
3.1
3.6
pmol/l
14.1
14.9
1.81
47
451
(3041096) Erythrocytes [Presence] in Urine by Automated
17
177
0.95
0.01
2.7
3.4
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
66
654
1.04
0.00
5.0
6.1
mmol/mol
37.6
40.3
1.96
61
607
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
11
114
0.96
0.00
1.3
1.3
iu/ml
11.8
36.0
—
5
44
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(4024509)
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
3.4
—
288.9
—
0
5
(3020491) Glucose [Moles/volume] in Blood
0
7
0.00
0.00
0.0
3.0
—
7.0
—
0
7
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
0
8
0.00
0.00
0.0
2.1
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.3
—
930.5
—
0
6
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
0
5
0.00
0.00
0.0
1.0
—
10.4
—
0
5
(3051593) INR in Capillary blood by Coagulation assay
0
6
0.00
0.00
0.0
11.7
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3019225) pH of Specimen
7
74
0.94
0.00
9.1
4.1
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.6
—
1.0
—
0
8
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
13.9
—
0
5
(3011648) Oxygen content in Venous blood
0
6
0.00
0.00
0.0
1.0
—
11.6
—
0
6
(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.4
—
66.4
—
0
5
(4027681)
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(4146454)
0
7
0.00
0.00
0.0
2.6
—
—
—
0
0
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(4062490)
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
6
59
1.02
0.00
3.0
2.0
—
—
—
0
0
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3020717) Zinc [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
11.9
—
0
5
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.5
—
203.7
—
0
6
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(4306422)
0
9
0.00
-0.00
0.0
1.1
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
0
9
0.00
-0.00
0.0
1.3
—
—
—
0
0
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
0
9
0.00
-0.00
0.0
1.1
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: C3_PALATE – Malignant neoplasm of palate
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).